reference/3747188

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3747188

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1067
issn	0008-543X 1097-0142
issueIdentifier	6
pageRange	1060-1067
publicationName	Cancer
startingPage	1060
bibliographicCitation	Boccardo F, Rubagotti A, Aldrighetti D, Buzzi F, Cruciani G, Farris A, Mustacchi G, Porpiglia M, Schieppati G, Sismondi P. Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials. Cancer. 2007 Mar 15;109(6):1060–7. doi: 10.1002/cncr.22513. PMID: 17295293.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2505-5716 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1aa895aeabec12fe8ef137c3da753528 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f3ae99f3b26105630074357adcdc124 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_235f838614e5aed47e018a7dad7558c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cf8380125433e4d062be1d8302e8377 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ae9991834b352ce4312bdf4d8fb5c07 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b35edcadaa92241ee9f6645a2d089dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2455f329dbe80ac4efe04969cc78ca9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbeea6d00486f9dd97e096319041ab79 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec5b0cf07ba5afb70977b2cdc9ca49d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc6ab96e453db436dea39c1d26f7241b
date	2007-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/17295293 https://doi.org/10.1002/cncr.22513
isPartOf	https://portal.issn.org/resource/ISSN/1097-0142 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2771 https://portal.issn.org/resource/ISSN/0008-543X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials
discusses	http://id.nlm.nih.gov/mesh/M0028300 http://id.nlm.nih.gov/mesh/M0456327 http://id.nlm.nih.gov/mesh/M0021024
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D047072Q000627 http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D002277Q000188 http://id.nlm.nih.gov/mesh/D002277Q000401 http://id.nlm.nih.gov/mesh/D001943Q000401
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D018931Q000627 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D013629Q000627 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D016896
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5d445780815638f183c8f68566998507 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2187 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2145 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128713593 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129157239 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129769972

Total number of triples: 55.